Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

NCI Alliance for Nanotechnology in Cancer

The NCI Alliance for Nanotechnology in Cancer, launched in 2004, is engaged in efforts to harness the power of nanotechnology to improve the way we diagnose, treat, and prevent cancer. The Alliance works in concert with other NCI advanced technology initiatives to provide the scientific foundation and team science that is required to transform cancer research and care.

The Alliance program aims to:

  • Address major barriers in cancer biology and/or oncology using nanotechnology
  • Enable mechanistic studies to expand the fundamental understanding of nanomaterial and/or nano-device interactions with biological systems
  • Advance new nanotechnology cancer discoveries and promote their transformation into cancer-relevant applications in clinical practice
  • Develop the next generation of cancer researchers in the area of nanotechnology
An animated gif of locations and institutions receiving IRCNs/TTNCIs grants in 2023. All are located within the continental United States, with a majority in the eastern part of the country.

The locations and institutions receiving IRCNs/TTNCIs grants in 2023

The Alliance’s programs foster innovation and collaboration among researchers within and between institutions, as well as across scientific disciplines.

Alliance Programs

Alliance Resources

Email